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The unit has received 889 patients with
myocardial infarction, of whom 159 have
been delivered directly by paramedics. Alto›
gether 495 of the patients have received
thrombolytic treatment, including 131 of
those delivered by the paramedics. The
mean (median) times from arrival in
hospital to thrombolysis (door to needle
times) were 89 (107) minutes for all patients
with acute myocardial infarction yet only 42
(43) minutes for those delivered by para›
medics. Altogether 171 patients given
thrombolysis who were admitted to the cor›
onary care unit direct from the accident and
emergency department had mean door to
needle times of 80 (76) minutes.
At present we do not give thrombolysis
in the accident and emergency department,
although this policy is under review. The
door to needle time that we achieve with our
paramedic direct admission service is simi›
lar to the Sheffield model of thrombolysis in
the accident and emergency department.
This model should also be considered as a
means of delivering thrombolysis more
quickly than traditional methods of admis›
sion to hospital. If thrombolysis starts to be
given in the accident and emergency
department in Chesterfield we will have to
compare this service with the existing para›
medic service and determine if the model
proposed by Edhouse et al is even quicker.
David A Sandler Consultant physician
Chesterfield and North Derbyshire Royal Hospital,
Chesterfield S44 5BL
DoctorDAS@aol.com
1 Call to needle times after acute myocardial infarction
[letters]. BMJ 1999;318:597›8. (27 February.)
2 Sandler DA. Paramedic direct admission of heart›attack
patients to a coronary care unit. Lancet 1998;352:1198.
GPs are encouraged to rely on ambulance
service
Editor—I was interested to see that the let›
ters criticising the paper by Rawles et al on
call to needle times after acute myocardial
infarction were written by trust employees.1 2
As a general practitioner practising immedi›
ate care and offering domiciliary thrombo›
lysis I wonder whether they have a genuine
wish to improve patient care, or are they
influenced by a powerful conflict of interest?3
As Edhouse et al and Ahmad et al
confirm,1 in an emergency most patients
make a 999 call for an ambulance in the
belief that an ambulance offers the quickest
route to hospital care and therefore the best
outcome. This need not be the case. As
Rawles et al show, at least in the case of acute
myocardial infarction, general practitioners
can offer an improved clinical outcome but
only if they are adequately equipped, readily
available, and mobilised in time.2
Few general practitioners currently offer
domiciliary thrombolysis or indeed any
other emergency medical care. Most receive
financial inducements to delegate out of
hours care to the cooperative deputising
services. Unfortunately, this means that in
many cases a doctor cannot be provided in
time to influence the clinical outcome when
one is genuinely needed. Delays in visiting of
more than an hour are now common, so it is
no surprise to learn that the corporatist
NHS hierarchy, in the form of the Sandwell
NHS Trust, encourages acutely ill patients to
bypass their general practitioner and dial
999 instead.1
Although official ambulance response
times in Suffolk often exceed 30 minutes
and the trust is under investigation by the
region for its poor performance, local
general practitioners are encouraged to rely
on the ambulance service in all acute cases
rather than provide a comprehensive service
themselves. On one occasion the ambulance
trust initially refused to contact me for a
patient in pulseless ventricular tachycardia
after its receipt of a 999 call, although I had
been asked for by name and was readily
available. In fact, I arrived well before the
ambulance and initiated treatment and the
patient survived. In a more recent but identi›
cal case I was called belatedly, only to
confirm death.
The provision of quality medical care by
general practitioners is greatly hampered by
unreasonable patient demand and trust cor›
porate philosophy. In consequence there
has been a reduction in general practition›
ers’ involvement and an increase in the use
of the ambulance service and accident and
emergency departments. I have yet to be
convinced, however, that patients receive
better treatment in consequence.
P D Thomas General practitioner
Gipping Valley Practice, Barham, Ipswich IP6 0AS
pault@gippingvalley.demon.co.uk
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New standard of 60 minutes has been
proposed but may be too rigorous
Editor—Since our paper was published1
and the responses to it were written,2 a new
standard call to needle time of 60 minutes
has been proposed.3 This supersedes the 90
minute standard set by the British Heart
Foundation.
In relation to these standards the table
shows up to date call to needle times from
the Grampian audit, comparing prehospital
thrombolysis by general practitioners in
rural areas with scoop and run in the city
and suburbs of Aberdeen and in rural areas
25 km or more from Aberdeen. In the scoop
and run cases, patients taken to hospital
after a 999 call were given thrombolytic
treatment either in the accident and
emergency department or in the coronary
care unit to which they were directly admit›
ted. No doctor to doctor referrals occurred
in these cases, so these times are about the
shortest that are achievable with this
approach.
These results suggest that the rigorous
60 minute call to needle standard is unlikely
to be achieved in most cases unless
thrombolysis is initiated in the community
before patients are transported to hospital.
John Rawles Honorary senior lecturer in medicine
Medicines Assessment Research Unit, University of
Aberdeen, Royal Infirmary, Aberdeen AB25 2ZN
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Emerging tobacco hazards in
China
Is assumption of no association between
smoking and other causes of death valid?
Editor—Liu et al used the term “propor›
tional mortality study” to describe their
method of comparing the smoking habits of
0.7 million adults who died of neoplastic,
respiratory, or vascular causes with those of
a reference group of 0.2 million who died of
other causes in China.1 The term can be
confusing as it is used only for proportional
mortality ratio analysis in standard epidemi›
ology textbooks.2 We suggest that the study
can be more easily understood if it is
described as a case›control mortality study.
An important assumption in such analy›
ses is that the other causes of death should
be unrelated to the exposure “not only in
the sense of causation but also in terms of
‘self›selection’ for the exposure and the
diagnosis and certification of the underlying
cause of death.”3 Liu et al validated this
assumption by showing that the smoking
rates of the male and female reference
groups were only slightly higher than those
of the surviving spouses of the people who
had died. However, they did not elaborate
whether this similarity was true for each city
or rural area in China, and, if it was not, why.
Could this similarity be a feature of
populations in which the tobacco epidemic
is at an early stage? The authors’ assumption
may not be valid in other studies (such as
our Hong Kong study4) or future studies that
use a similar design. One potential con›
founding factor is social class, which is often
associated with both smoking and mortality,
and it may lead to an association between
smoking and other causes of death. Studies
elsewhere have observed some association
between smoking and other causes of death
(for example, in the American Cancer Soci›
ety’s cohort the mean annual mortality from
other medical causes was 39/100 000 men
Audit of call to needle times after acute
myocardial infarction in Grampian in relation to
proposed standard of <60 minutes3 and British








Proportion (%) in whom call to needle time was:
<60 min 156/211 (74) 40/84 (48) 1/13 (8)
<90 min 198/211 (94) 70/84 (83) 8/13 (62)
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in never smokers and 81/100 000 in current
smokers)5; choosing such other causes as
referents would underestimate the risks
from smoking.
It is fairly easy to define a priori which
are the other causes of death for smokers as
relations between smoking and many dis›
eases are known, but it is difficult to define
them when other risk factors (such as
alcohol consumption) are studied in relation
to mortality. Information on smoking (and
confounders and other risk factors) in
another control group randomly selected
from the surviving population should be
collected for validation; if the results do not
support the assumption, classical case›
control analysis comparing the dead and the
living is necessary.
T H Lam Professor
S Y Ho Researcher
Department of Community Medicine, University of
Hong Kong, Hong Kong, China
commed@hkucc.hku.hk
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Double standards apply with importation
of tobacco into developing countries
Editor—Smoking is a scourge that, although
universal in distribution, ravages the econo›
mies of developing countries both directly
and indirectly. As a non›medical person, I
acknowledge with admiration the moral and
economic purpose behind studies such as
those by Liu et al and Niu et al.1 2 I wonder,
however, about the lack of speculation in the
papers, let alone recommendations, on the
possible measures that governments, health
bodies, and non›governmental associations
should undertake to combat what is obvi›
ously a healthcare disaster. Given the press
coverage that high impact papers such as
these attract and that the BMJ’s readership
extends to the non›medical world, Lopez in
particular missed the opportunity to put this
right in his editorial.3
In the electronic responses to these stud›
ies Pletten attempts to rectify this.4 But his
triumphalism—that China should learn from
the United States’ experience of dealing with
tobacco—displays the ignorance that indi›
viduals with his views have of the enormous
contribution made by the United States to
the importation of tobacco into developing
countries. More sensitive people in the West›
ern world would find disturbing the fact that
cigarette packets intended for sale in the
West bear health warnings such as “cigarette
smoking kills” and “cigarette smoking causes
cancer” whereas those intended for sale in
the developing world bear warnings diluted
of impact, such as “cigarette smoking may be
injurious to health” and “cigarette smoking
may damage your health”—both in English
and in the language used locally. The ethics,
or lack thereof, of the parties concerned is
obvious.
Medical researchers are often in a
powerful position when it comes to influenc›
ing healthcare decisions and should use this
for the public good. Now that these papers
have proved the obvious, perhaps we should
do something about it.
Yonden Lhatoo Editor
Asia Television, Hong Kong, China
ycharlie@hk.super.net
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UK authors’ reply
Editor—Three different types of study have
led to virtually identical conclusions about
smoking and death in China1 2:
(1) A case›control study in which the
smoking habits of one million people who
had died were compared with those of
300 000 who had not1
(2) A prospective study of 250 000
adults, 10 000 of whom had died2;
(3) What we chose to call a proportional
mortality study, in which the smoking habits
of 700 000 adults who had died of neoplastic,
respiratory, or vascular disease were com›
pared with those of a reference group of
200 000 adults who had died of other causes.1
To avoid confusion between the second
and third of these, we are reluctant to adopt
Lam’s suggestion of calling the third a case›
control mortality study, but the choice of
terminology is not very important. What
chiefly matters is the results: already there
are almost a million deaths a year from
smoking in China, and eventually there will
be two or three million a year. These facts
were not appropriately widely accepted until
these studies were done, and their wide
acceptance may well be achieved more rap›
idly if (despite Lhatoo’s concerns) the
findings are presented without any strong
recommendations other than that they
should be widely known. Both papers are
available in translation in the February 1999
Chinese language edition of the BMJ.
Richard Peto Professor
Zheng›Ming Chen Reader
Jillian Boreham Senior research officer
Clinical Trial Service Unit, Nuffield Department of
Clinical Medicine, Radcliffe Infirmary, Oxford
OX2 6HE
gale.mead@ctsu.ox.ac.uk
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I don’t want to be invited to
invest in the tobacco trade
Editor—The British Heart Foundation was
criticised by the Independent on Sunday last
year for using pension funds that invested in
tobacco companies.1 A spokesperson for the
BMA commented that charities promoting
health should, as a matter of principle, avoid
investment in tobacco companies and that
“charities campaigning against tobacco
should certainly not invest in tobacco
stock.”1 However, the BMJ and the BMA
(through its financial services subsidiary)
could be criticised on similar grounds as
both promote saving and pension funds
investing in tobacco stocks. Last year the
BMJ carried a full page advertisement for
the Royal National Pension Fund for Nurses
promoting “an outstanding investment
opportunity.”2 I would have hoped that
saving and pension funds designed for
health professionals would avoid tobacco
investment, but the Royal National Pension
Fund for Nurses was unable to provide reas›
surance on this when I wrote to it. As the
Independent on Sunday has shown, pension
and savings funds, unless specifically
screened, commonly invest in tobacco stocks
because they are profitable.1
BMA Services also continues to pro›
mote funds that have no screening to
exclude tobacco investment. Indeed, when I
wrote to the company about this it replied
that “many doctors require consistent
growth in preference to investing ethically.”
At a time when pension and savings funds
that offer both consistent growth and
tobacco›free investment do exist, I find it
disturbing to receive promotional literature
tucked in my BMJ inviting me to invest in the
tobacco trade.
Chris Johnstone Clinical assistant in addictions
24a Balmoral Road, Bristol BS7 9AZ
100676.624@compuserve.com
1 Woolf M. Heart charity invests in tobacco industry.
Independent on Sunday 1998 Dec 6:1 (cols 1›2).
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Women must be given fully
informed information about
cervical screening
Editor—The General Medical Council has
now produced clear ethical guidelines with
respect to getting informed consent from
patients undergoing any medical procedure,
including screening tests.1 2 This would
include cervical screening.
The guidelines are quite specific in
stating that a doctor or other party should
explain the purpose of screening; the
likelihood of positive and negative findings,
including false negative and false positive
results; uncertainties and risks of screening;
important medical, social, or financial
consequences of screening; and follow up
plans, including counselling and support
services. Several other, more general, points
may also apply to screening, such as
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